Image

Global Syndromic Multiplex Diagnostic Market – Industry Trends and Forecast to 2031

Medical Devices

Image

Global Syndromic Multiplex Diagnostic Market – Industry Trends and Forecast to 2031

  • Medical Devices
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Syndromic Multiplex Diagnostic Market, By Product and Services (Reagents & Consumables, Instruments, Software & Accessories, Services), Infection Type (Viral, Bacterial, Parasites, Fungal), Disease (Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Sepsis, Meningitis, Others), Panels Type (Respiratory Panel, GI-Enteric Panel, Sexually Transmitted Disease Panel, Blood-Sepsis Panel, Meningitis panel, Others), End User (Clinical Laboratories, Hospitals, Pharmaceutical & Biotechnology Companies, Research Institutes, Others) - Industry Trends and Forecast to 2031.

Syndromic Multiplex Diagnostic Market

Syndromic Multiplex Diagnostic Market Analysis and Size

Syndromic multiplex diagnostics offer the simultaneous testing of multiple pathogens, enabling healthcare professionals to quickly identify the cause of infections. The market is propelled by the rising incidence of infectious diseases, the need for prompt diagnosis in emergency settings, and the growing awareness about the benefits of multiplex testing in guiding appropriate treatment decisions. The integration of molecular diagnostics and syndromic testing approaches is anticipated to further enhance the capabilities of these diagnostic tools, fostering market growth in the coming years.

Data Bridge Market Research analyzes that the global syndromic multiplex diagnostic market which was USD 2.52 billion in 2023, is likely to reach USD 5.05 billion by 2031, and is expected to undergo a CAGR of 6.1% during the forecast period. “Reagent and consumables" dominates the product and services segment of the market due to increasing awareness of proper diagnostics. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Syndromic Multiplex Diagnostic Market Scope and Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product and Services (Reagents & Consumables, Instruments, Software & Accessories, Services), Infection Type (Viral, Bacterial, Parasites, Fungal), Disease (Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Sepsis, Meningitis, Others), Panels Type (Respiratory Panel, GI-Enteric Panel, Sexually Transmitted Disease Panel, Blood-Sepsis Panel, Meningitis panel, Others), End User (Clinical Laboratories, Hospitals, Pharmaceutical & Biotechnology Companies, Research Institutes, Others)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of the Middle East & Africa

Market Players Covered

BioFire Diagnostics (A Subsidiary of bioMérieux SA), Seegene Inc. (South Korea), Luminex Corporation. A DiaSorin Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cepheid (A subsidiary of Danaher (U.S.)), QIAGEN (Germany), Abbott (U.S.), Hologic, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Siemens Healthcare GmbH (Germany), Akonni Biosystems, Inc. (U.S.), Biocartis (Belgium), QuantuMDx Group Ltd. (U.K.), Bosch Healthcare Solutions GmbH (A Subsidiary Of Robert Bosch GmbH) (Germany), Applied BioCode, Inc. (U.S.), Prominex Inc. (U.S.), Nanomix, Inc. (U.S.), Curetis (A subsidiary of OpGen, Inc.) (Germany), MiRXES Pte Ltd (Singapore)

Market Opportunities

  • Telehealth integration
  • Technological advancements

Market Definition
Syndromic multiplex diagnostic is a type of advanced diagnostic test utilized to detect infectious diseases such as respiratory infection, infective gastroenteritis, sexually transmitted infections, sepsis, and meningitis, among other types of infectious diseases. The syndromic multiplex diagnostic also helps clinics or hospitals to detect the symptoms and signs of the various types of diseases. This lets the healthcare providers provide the right treatment for the patients and offer more precise outcomes and care that can be performed more quickly.

Global Syndromic Multiplex Diagnostic Market Dynamics

Drivers

  • Rising Incidence of Infectious Diseases

The increasing prevalence of infectious diseases, including respiratory infections and sexually transmitted diseases, is a significant driver. Syndromic multiplex diagnostic tests enable the simultaneous detection of various pathogens, aiding in the prompt identification and treatment of infections.

  • Demand for Rapid and Accurate Diagnostics

There is a growing demand for diagnostic tools that offer quick and accurate results, particularly in emergency settings. Syndromic multiplex diagnostics fulfill this need by providing a comprehensive analysis of multiple pathogens in a single test, reducing the time required for diagnosis.

  • Advancements in Diagnostic Technologies

Ongoing advancements in diagnostic technologies, such as nucleic acid amplification techniques and microarray technologies, contribute to the improved performance and accuracy of syndromic multiplex diagnostics, driving market growth.

Opportunities

  • Emergence of Point-of-Care Testing

The increasing focus on point-of-care testing presents an opportunity for syndromic multiplex diagnostics. Portable and user-friendly diagnostic devices that can deliver rapid results at the point of care have the potential to enhance the adoption of multiplex testing.

  • Integration with Electronic Health Records (EHR)

The integration of syndromic multiplex diagnostic data with electronic health records offers opportunities for better patient management and comprehensive healthcare decision-making.

Restraints/Challenges

  • High Cost of Multiplex Diagnostic Tests

The cost associated with developing and conducting multiplex diagnostic tests can be a significant challenge. High expenses may limit their accessibility, especially in resource-constrained healthcare settings

  • Complexity in Data Interpretation

The interpretation of results from multiplex diagnostic tests can be complex, requiring trained professionals. This complexity may pose a challenge, particularly in regions with a shortage of skilled healthcare personnel.

Global Syndromic Multiplex Diagnostic Market Scope

The syndromic multiplex diagnostic market is segmented on the basis of product and services, infection type, disease, panels type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and Services

  • Reagents & Consumables
  • Instruments
  • Software & Accessories
  • Services

Infection Type

  • Viral
  • Bacterial
  • Parasites
  • Fungal

Disease

  • Respiratory Infection
  • Gastroenteritis
  • Sexually Transmitted Infections
  • Sepsis
  • Meningitis
  • Others

Panels Type

  • Respiratory Panel
  • GI-Enteric Panel
  • Sexually Transmitted Disease Panel
  • Blood-Sepsis Panel
  • Meningitis Panel
  • Others

End User

  • Hospitals
  • Clinical Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Others

Global Syndromic Multiplex Diagnostic Market Regional Analysis/Insights

The syndromic multiplex diagnostic market is analyzed and market size insights and trends are provided based on product and services, infection type, disease, panels type and end user.

The regions covered in the market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Switzerland, Russia, Turkey, Belgium, rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Philippines and rest of Asia-Pacific, Brazil, Argentina and Rest of South America, South Africa, Saudi Arabia, U.A.E., Israel, Egypt and rest of Middle East and Africa.

North America is expected to dominate the market and show the fastest growth due to the region's high healthcare expenditure and the increasing awareness about the syndromic multiplex diagnostic.

The country section of the report also provides individual market impacting factors and domestic regulation changes that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.     

Competitive Landscape and Global Syndromic Multiplex Diagnostic Market Share Analysis

The syndromic multiplex diagnostic market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to syndromic multiplex diagnostic market.

Some of the major players operating in the syndromic multiplex diagnostic market are:

  • BioFire Diagnostics (A Subsidiary of bioMérieux SA)
  • Seegene Inc. (South Korea)
  • Luminex Corporation. A DiaSorin Company (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • BD (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Cepheid (A subsidiary of Danaher (U.S.))
  • QIAGEN (Germany)
  • Abbott (U.S.)
  • Hologic, Inc. (U.S.)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Siemens Healthcare GmbH (Germany)
  • Akonni Biosystems, Inc. (U.S.)
  • Biocartis (Belgium)
  • QuantuMDx Group Ltd. (U.K.)
  • Bosch Healthcare Solutions GmbH (A Subsidiary of Robert Bosch GmbH) (Germany)
  • Applied BioCode, Inc. (U.S.)
  • Prominex Inc. (U.S.)
  • Nanomix, Inc. (U.S.)
  • Curetis (A subsidiary of OpGen, Inc.) (Germany)
  • MiRXES Pte Ltd (Singapore)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Syndromic Multiplex Diagnostic Market size will be worth USD 5.05 billion by 2031 during the forecast period.
The Syndromic Multiplex Diagnostic Market growth rate is 6.1% during the forecast period.
The Rising Incidence of Infectious Diseases, Advancements in Diagnostic Technologies, Demand for Rapid and Accurate Diagnostics are the growth drivers of the Syndromic Multiplex Diagnostic Market.
The product and services, infection type, disease, panels type and end user are the factors on which the Syndromic Multiplex Diagnostic Market research is based.
The major companies in the Syndromic Multiplex Diagnostic Market are BioFire Diagnostics (A Subsidiary of bioMérieux SA), Seegene Inc. (South Korea), Luminex Corporation. A DiaSorin Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cepheid (A subsidiary of Danaher (U.S.)), QIAGEN (Germany), Abbott (U.S.), Hologic, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Siemens Healthcare GmbH (Germany), Akonni Biosystems, Inc. (U.S.), Biocartis (Belgium), QuantuMDx Group Ltd. (U.K.), Bosch Healthcare Solutions GmbH (A Subsidiary Of Robert Bosch GmbH) (Germany), Applied BioCode, Inc. (U.S.), Prominex Inc. (U.S.), Nanomix, Inc. (U.S.), Curetis (A subsidiary of OpGen, Inc.) (Germany), MiRXES Pte Ltd (Singapore).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials